AIN Holdings Inc
TSE:9627
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BayWa AG
XETRA:BYW6
|
DE |
|
M
|
MAG Holdings Berhad
KLSE:MAGNUM
|
MY |
AIN Holdings Inc
EPS (Diluted)
AIN Holdings Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
AIN Holdings Inc
TSE:9627
|
EPS (Diluted)
¥345
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
|
Tsuruha Holdings Inc
TSE:3391
|
EPS (Diluted)
¥144
|
CAGR 3-Years
13%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Welcia Holdings Co Ltd
TSE:3141
|
EPS (Diluted)
¥92
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
EPS (Diluted)
¥248
|
CAGR 3-Years
34%
|
CAGR 5-Years
17%
|
CAGR 10-Years
1%
|
|
|
MatsukiyoCocokara & Co
TSE:3088
|
EPS (Diluted)
¥140
|
CAGR 3-Years
16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-2%
|
|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
EPS (Diluted)
¥395
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
AIN Holdings Inc
Glance View
AIN Holdings Inc., a prominent player in Japan's healthcare and pharmaceutical retail sector, stands as a testament to its vision and strategic execution. The company, founded in 1974, began its journey with a simple yet ambitious goal: to provide accessible and quality pharmaceutical products to the Japanese populace. Over the decades, it has meticulously built a network of drugstores and dispensing pharmacies, skillfully navigating the complexities of Japan's rigorous healthcare regulations. Its flagship brand, Ainz & Tulpe, exemplifies the company’s innovative approach, offering not just pharmaceuticals but also integrating cosmetics and health merchandise, thereby creating a one-stop shop for health and wellness needs. This unique retail concept enhances customer convenience and brings a diverse array of products under a single roof, driving foot traffic and boosting sales. A significant portion of AIN Holdings' revenue flows from its dispensing pharmacy division, which benefits from Japan's aging population and the increasing demand for prescription medications. By strategically positioning its outlets near hospitals and clinics, AIN Holdings ensures a continuous influx of customers needing prescription refills and healthcare advice. Beyond the retail front, the company is also committed to leveraging digital platforms to streamline operations and enhance customer experience, such as online prescriptions and delivery services. These strategies not only increase efficiency but also bolster customer loyalty as convenience becomes a crucial differentiator in the retail pharmacy landscape. As the company continues to expand both domestically and internationally, AIN Holdings remains focused on adapting to evolving market needs while maintaining its core philosophy of supporting health and well-being through accessible and comprehensive pharmaceutical care.
See Also
What is AIN Holdings Inc's EPS (Diluted)?
EPS (Diluted)
345.2
JPY
Based on the financial report for Jan 31, 2026, AIN Holdings Inc's EPS (Diluted) amounts to 345.2 JPY.
What is AIN Holdings Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
4%
Over the last year, the EPS (Diluted) growth was 21%. The average annual EPS (Diluted) growth rates for AIN Holdings Inc have been 17% over the past three years , 13% over the past five years , and 4% over the past ten years .